×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

VIVO CAPITAL, LLC

AUM: $5.81 B
13-F Portfolio Value: $1.21 B
Last 13-F Filed: Q3 2024
Concentration in top 10: 77.54%
Filter by:
Stock Company % Portfolio Shares Held Market Value Change in Shares % Change Quarter End Price Source
AADIAadi Bioscience Inc-509,572Exited13F
ALGSAligos Therapeutics Inc-3,547,030Exited13F
AVDLAvadel Pharmaceuticals PLC-3,972,099Exited13F
TARSTarsus Pharmaceuticals Inc-565,550Exited13F
ZLABZai Lab Ltd-531,198Exited13F